NCT02640183 is a Phase 2 clinical trial of EMLA in Anesthetics, Local, sponsored by Ain Shams Maternity Hospital.

Who is sponsoring NCT02640183?

NCT02640183 is sponsored by Ain Shams Maternity Hospital.

What drugs are being tested in NCT02640183?

Interventions in NCT02640183: EMLA, Placebo.

What condition does NCT02640183 study?

NCT02640183 studies Anesthetics, Local.

Is NCT02640183 still recruiting?

NCT02640183 is currently status unknown. Last updated 22 December 2015.

Last reviewed 2015-12-22 · How we verify

NCT02640183

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lidocaine-Prilocaine (EMLA®) Cream in Hysteroscopy Practice: A Prospective Randomized Non-blinded Controlled Study

Status unknown Phase 2 Last updated 22 December 2015

What this trial tests

Phase 2 trial testing EMLA in Anesthetics, Local in 184 participants. Status unknown.

Timeline

1 September 2015

Primary endpoint
1 March 2016

1 March 2016

Quick facts

Lead sponsor	Ain Shams Maternity Hospital
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	184
Start date	1 September 2015
Primary completion	1 March 2016
Estimated completion	1 March 2016

Drugs / interventions tested

EMLA — full drug profile →
Placebo

Conditions studied

Anesthetics, Local — all drugs for Anesthetics, Local →

Sponsor

Ain Shams Maternity Hospital

Who can join

18 and older, female only, with Anesthetics, Local. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Pain experienced during the procedure scored using a VAS.
Time frame: Procedure
All women will be asked to score the pain they experienced during the procedure using a VAS that consists of a 10-cm line scaled from 0 to 10 (0 = no pain and 10 = severe pain). Women will be asked to verbally specify the number that represented their level of perceived pain intensity during the hysteroscopy immediately after the procedure. After completing the hysteroscopy, women will be asked i

Sponsor's own description

The aim of this study is to investigate the efficacy of 5% lidocaine 25 mg-prilocaine 25 mg/g cream (EMLA®) applied to the uterine cervix for reducing pain during diagnostic hysteroscopy, using a visual analogue scale (VAS) for pain, and whether it can replace general anesthesia that may be required for some cases of office hysteroscopy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pain relief for outpatient hysteroscopy.
Ahmad G, Saluja S, O'Flynn H, Sorrentino A, et al · · 2017 · cited 34× · PMID 35611933 · DOI 10.1002/14651858.cd007710.pub3

Verify or expand the search:

Other trials of EMLA

Trials testing the same drug.

NCT06274905 — Topical Anaesthesia in Cutaneous Head and Neck Surgery · NA · completed
NCT04003012 — Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures · Phase 4 · completed
NCT03654417 — Pain Perception During Vulvar Biopsy · Phase 4 · terminated
NCT01516684 — Local Anesthetic Cream in Younger Patients Undergoing Lumbar Punctures · Phase 2 · completed

Other Ain Shams Maternity Hospital trials

Trials by the same sponsor.

NCT07514078 — Evaluation of Laparoscopic Staging Versus Staging Laparotomy for Early Stage Endometrial Cancer · NA · not yet recruiting
NCT07308977 — Practice of Assisted Vaginal Birth in Egypt · not yet recruiting
NCT06935422 — Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complic · recruiting
NCT06524700 — Pectopexy Autologous Vs Mesh · NA · active not recruiting
NCT07247851 — Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02640183 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams Maternity Hospital
Last refreshed: 22 December 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02640183.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing